EXHIBIT 32
CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Abeona Therapeutics Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Brian Pereira, Executive Chairman of the Company, and Edward Carr, Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: | May 6, 2020 | By: | /s/ Brian Pereira |
Brian Pereira | |||
Executive Chairman | |||
(Principal Executive Officer) | |||
Date: | May 6, 2020 | By: | /s/ Edward Carr |
Edward Carr | |||
Chief Accounting Officer | |||
(Principal Financial Officer) |